Government Reform Committee
This article was originally published in The Tan Sheet
Executive Summary
House hearing on dietary supplement issues scheduled to be held Feb. 28. Potential points of discussion and testimony include Codex, ephedra, Pearson implementation and GMPs. Committee Chairman Dan Burton (R-Ind.) postponed a Dec. 27 hearing on FDA's position regarding ephedrine alkaloid-containing supplements after receiving confirmation from FDA it had no plans to act immediately on the matter (1"The Tan Sheet" Jan. 8, p. 11)